Monica R. Thomas - 22 May 2023 Form 4 Insider Report for G1 Therapeutics, Inc.

Role: General Counsel
Signature: /s /Sandi James, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 22 May 2023
Net transactions value: $0
Form type: 4
Filing time: 24 May 2023, 16:41:16 UTC
Next filing: 08 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GTHX	Common Stock	Award	$0	+50,000	+28409%	$0.000000	50,176	22 May 2023	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GTHX	Stock Options (Right to buy)	Award	$0	+150,000		$0.000000	150,000	22 May 2023	Common Stock	150,000	$2.88	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit ("RSU") award that vests 25% on May 22, 2024 and 25% annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
F2	Each RSU represents a contingent right to receive one share of Issuer common stock.
F3	Represents (i) 176 shares of common stock; and (ii) 50,000 RSUs from award granted on May, 22 2023.
F4	The shares underlying this option vest as to 25% of the shares on May 22, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.